2023

Paper A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care January 18, 2024 Systematic Review of peer-reviewed quantitative studies and conference abstracts addressing PrEP screening, prescribing, and/or linkage to PrEP care in US Emergency Departments. Further research into the best practices for integrating ED […]

Read More
2023
A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care

January 18, 2024

Infographic Pharmacist-initiated naloxone and syringe furnishing in California January 18, 2024 Infographic highlighting some of the results from the 2022 California Pharmacist Survey. Pharmacists were asked about their furnishing of naloxone and syringe without an outside provider’s prescription. Includes some policy implications.   — Image by Freepik Download Authors Northern California HIV/AIDS Policy Research Center

Read More
2023
Pharmacist-initiated naloxone and syringe furnishing in California

January 18, 2024

Infographic Phase II: Assessing Smoking Cessation Services in Central and Northern California HIV Safety Nets January 17, 2024 This publication is phase II of an audit or “secret shopper” study that sought to characterize current access to smoking cessation services in Central and Northern California HIV safety nets and to identify potential strategies for increasing […]

Read More
2023
Phase II: Assessing Smoking Cessation Services in Central and Northern California HIV Safety Nets

January 17, 2024

Fact Sheet Lens: HIV Prevalence and Mpox Vulnerabilities – A Data Mapping Tool December 19, 2023 The COVID-19 pandemic has renewed concerns about social and structural factors related to health disparities, including those related to HIV. The Lens tool is a partial response to an urgent need to understand whether elevated risk of COVID-19 disease […]

Read More
2023
Lens: HIV Prevalence and Mpox Vulnerabilities – A Data Mapping Tool

December 19, 2023

Policy Brief Impact of the Inflation Reduction Act on the 340B Program December 4, 2023 The 340b program provides an important revenue source for many HIV clinics and facilities, but that revenue is dependent on drug pricing. The Inflation Reduction Act of 2022 introduced provisions to curb drug pricing. Our modeling suggests that 340b revenues […]

Read More
2023
Impact of the Inflation Reduction Act on the 340B Program

December 4, 2023

Paper “Am I going to have to run to get out of this place?” A qualitative study exploring HIV clinical and service provider experiences from California regions heavily impacted by climate disaster October 25, 2023 In California, disaster events and extreme conditions caused by climate change are becoming more frequent and intense, impacting many regions […]

Read More
2023
“Am I going to have to run to get out of this place?” A qualitative study exploring HIV clinical and service provider experiences from California regions heavily impacted by climate disaster

October 25, 2023

Infographic Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment October 20, 2023 A new CHPRC analysis reveals California pharmacists’ preferences for implementing pharmacist-initiated PrEP for HIV prevention under Senate Bill 159. In a discrete choice experiment, pharmacists preferred implementation scenarios in which they play an active role in the PrEP […]

Read More
2023
Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment

October 20, 2023

Policy Brief Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment October 20, 2023 A new CHPRC analysis reveals California pharmacists’ preferences for implementing pharmacist-initiated PrEP for HIV prevention under Senate Bill 159. In a discrete choice experiment, pharmacists preferred implementation scenarios in which they play an active role in the […]

Read More
2023
Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment

October 20, 2023

Infographic Modeling the Impact of Supervised Consumption Sites on HIV and HCV Transmission among People who Inject Drugs in Three California Counties October 11, 2023 Supervised consumption sites (SCS) are harm reduction programs in which people who inject drugs (PWID) bring their previously obtained drugs to consume in a supervised setting. We modeled the potential […]

Read More
2023
Modeling the Impact of Supervised Consumption Sites on HIV and HCV Transmission among People who Inject Drugs in Three California Counties

October 11, 2023